Articles From This Issue
MIGS MUSINGS
A Practical Approach to MIGS
By Jeremy M. Cotliar, MD
In an urban private practice, patients’ socioeconomic status plays a prominent role in treatment decision-making.
CASE FILES
Subtle Rim Thinning in a Glaucoma Suspect
By Devesh K. Varma, B ENG, MD, FRCSC; David S. Friedman, MD, MPH, PhD; and Manjool Shah, MD
Is treatment indicated in this asymptomatic patient?
FEATURE
Community Vision Screening
By Elaine Han; Alexandra E. Levitt, MD, MPH; and Richard K. Lee, MD, PhD
A closer look at the potential impact and ideal framework.
Supplements and CME
A MIGS Case Study
Sponsored by Sight Sciences
The Xen Gel Stent in Pseudophakic Refractory Glaucoma Patients
Sponsored by Allergan
NEWS
EyeGate Pharma Submits Investigational Device Exemption Amendment for Second Pil…
EyeGate Pharmaceuticals announced that it has submitted an amended Investigational Device Exemption …
Icon Bioscience Receives FDA Approval for Dexycu Drug Therapy for Treating Infla…
Icon Bioscience announced that the FDA has approved the company's new drug application for Dexyc…
EyeGate Announces Topline Results for Phase 2b Trial of EGP-437 in Cataract Surg…
EyeGate Pharmaceuticals announced topline results from a phase 2b study of EGP-437 combination produ…
Patients Are Going Blind Due to 6-Month Waiting Lists for Cataract Surgery
Patients face going blind while waiting for cataract surgery after new figures showed waiting times …
Featured Content
